Gary M. Strauss

7.3k total citations · 3 hit papers
103 papers, 5.4k citations indexed

About

Gary M. Strauss is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary M. Strauss has authored 103 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary M. Strauss's work include Lung Cancer Diagnosis and Treatment (54 papers), Lung Cancer Treatments and Mutations (53 papers) and Lung Cancer Research Studies (21 papers). Gary M. Strauss is often cited by papers focused on Lung Cancer Diagnosis and Treatment (54 papers), Lung Cancer Treatments and Mutations (53 papers) and Lung Cancer Research Studies (21 papers). Gary M. Strauss collaborates with scholars based in United States, Italy and Canada. Gary M. Strauss's co-authors include David J. Sugarbaker, Steven J. Mentzer, Steven Swanson, Elizabeth H. Baldini, James E. Herndon, Malcolm M. DeCamp, Michael A. Maddaus, David H. Harpole, David W. Johnstone and Dorothy Watson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

Gary M. Strauss

101 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

1999 697 citations David J. Sugarbaker, Raja M. Flores et al. Journal of Thoracic and Cardiovascular Surgery profile →
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

2008 690 citations Gary M. Strauss, James E. Herndon et al. Journal of Clinical Oncology profile →
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

2012 464 citations Michael T. Jaklitsch, Francine L. Jacobson et al. Journal of Thoracic and Cardiovascular Surgery profile →

Peers

Countries citing papers authored by Gary M. Strauss

Since Specialization

Citations

This map shows the geographic impact of Gary M. Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Strauss more than expected).

Fields of papers citing papers by Gary M. Strauss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Strauss. The network helps show where Gary M. Strauss may publish in the future.

Co-authorship network of co-authors of Gary M. Strauss

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Strauss. A scholar is included among the top collaborators of Gary M. Strauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Strauss. Gary M. Strauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting 2016 ·Acta Dermato Venereologica ·Line Raaby, Claus Zachariae, Monika Østensen, Lene Heickendorff, Peter Thielsen, Henning Grønbæk, Lone Skov, N.C. Kyvsgaard, Jan Lysgaard Madsen, Michael Heidenheim, Anne T. Funding, Gary M. Strauss, R. B. Lindberg, Lars Iversen	41
2	Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER–Medicare analysis 2015 ·Annals of Oncology ·Jyoti Malhotra, Grace Mhango, Jorge Gómez, Cardinale B. Smith, Matthew D. Galsky, Gary M. Strauss, Juan P. Wisnivesky	25
3	Computed Tomography (CT) and Chest X-ray (CXR) Screening for Lung Cancer (LC): Mortality (MORT), Survival (SURV), and Randomized Population Trials (RPTs) - Analysis of the Mayo Lung Project (MLP) and the National Lung Screening Trial (NLST) 2015 ·CHEST Journal ·Gary M. Strauss, (unknown), Lorenzo Dominioni	1
4	Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America 2012 ·Journal of Thoracic and Cardiovascular Surgery ·Francine L. Jacobson, John H. M. Austin, John K. Field, James R. Jett, Shaf Keshavjee, Heber MacMahon, James L. Mulshine, Reginald F. Munden, Ravi Salgia, Gary M. Strauss, David J. Sugarbaker, Steven Swanson, William D. Travis, Michael T. Jaklitsch	84
5	The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups breakdown → 2012 ·Journal of Thoracic and Cardiovascular Surgery ·Michael T. Jaklitsch, Francine L. Jacobson, John H. M. Austin, John K. Field, James R. Jett, Shaf Keshavjee, Heber MacMahon, James L. Mulshine, Reginald F. Munden, Ravi Salgia, Gary M. Strauss, Steven Swanson, William D. Travis, David J. Sugarbaker	464
6	Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633 2010 ·Journal of Thoracic Oncology ·Stephen L. Graziano, Lin Gu, Xiaofei Wang, Arthur H. Tatum, Robin T. Vollmer, Gary M. Strauss, Robert A. Kratzke, Arkadiusz Z. Dudek, Everett E. Vokes, Mark R. Green	22
7	Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study 2009 ·Journal of Neuro-Oncology ·Steven W. Hwang, (unknown), Andrew T. Hale, (unknown), Tomáš Dvořák, Kevin C. Yao, Rolf Pfannl, John E. Mignano, Jay‐Jiguang Zhu, Lori Lyn Price, Gary M. Strauss, Julian K. Wu	52
8	Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups breakdown → 2008 ·Journal of Clinical Oncology ·Gary M. Strauss, James E. Herndon, Michael A. Maddaus, David W. Johnstone, Elizabeth A. Johnson, David H. Harpole, Heidi H. Gillenwater, Dorothy Watson, David J. Sugarbaker, Richard L. Schilsky, Everett E. Vokes, Mark R. Green	690
9	PRS-01: The epidemic of smoking-related adenocarcinoma of the lung: The role of the tobacco industry and filtered and low-tar cigarettes 2007 ·Journal of Thoracic Oncology ·Gary M. Strauss, Ahmedin Jemal, (unknown), (unknown), K. Michael Cummings	9
10	Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk 2007 ·BMJ Quality & Safety ·Susan Kirsh, Sharon A. Watts, (unknown), (unknown), D C Davidson, Gary M. Strauss, (unknown), David C. Aron	110
11	Screening for Lung Cancer 2000 ·Chest Surgery Clinics of North America ·Lorenzo Dominioni, Gary M. Strauss, Andrea Imperatori, Francesca Rovera, Gianlorenzo Dionigi	1
12	Perception, paradox, paradigm 2000 ·Cancer ·Gary M. Strauss, Lorenzo Dominioni	14
13	Varese meeting report 1999 ·Lung Cancer ·Gary M. Strauss, Lorenzo Dominioni	19
14	Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients breakdown → 1999 ·Journal of Thoracic and Cardiovascular Surgery ·David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch, William G. Richards, Gary M. Strauss, Joseph M. Corson, Malcolm M. DeCamp, Steven Swanson, Raphael Bueno, Jeanne M. Lukanich, Elizabeth H. Baldini, Steven J. Mentzer	697
15	High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234 1999 ·Annals of Oncology ·N. J. Vogelzang, James E. Herndon, Antonius A. Miller, Gary M. Strauss, Gerald H. Clamon, F. Marc Stewart, Joseph Aisner, Alan P. Lyss, M. Robert Cooper, Yota Suzuki, M. R. Green	32
16	Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. 1995 ·Journal of Clinical Oncology ·Gary M. Strauss, D J Kwiatkowski, David H. Harpole, Thomas J. Lynch, Arthur T. Skarin, David J. Sugarbaker	126
17	Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression 1994 ·British Journal of Haematology ·I Tepler, Anthony Elias, Leslie A. Kalish, Lawrence N. Shulman, Gary M. Strauss, Arthur T. Skarin, Thomas J. Lynch, Daniel Levitt, Debra Resta, G. D. Demetri, (unknown), Lowell E. Schnipper	14
18	Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer 1993 ·Journal of Thoracic and Cardiovascular Surgery ·David H. Kirn, Thomas J. Lynch, Steven J. Mentzer, Thomas H. Lee, Gary M. Strauss, Anthony Elias, Arthur T. Skarin, David J. Sugarbaker	22
19	Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer 1992 ·Cancer Chemotherapy and Pharmacology ·Joseph Aisner, Margaret Whitacre, Daniel R. Budman, (unknown), Gary M. Strauss, David A. Van Echo, Michael C. Perry	14
20	Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. 1992 ·Journal of Clinical Oncology ·Gary M. Strauss, James E. Herndon, (unknown), Douglas J. Mathisen, Robert W. Carey, Noah C. Choi, Vishram B. Rege, Caron Modeas, (unknown)	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact